BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 5081005)

  • 21. The use of chromatography to manufacture purer and safer plasma products.
    Johnston A; Adcock W
    Biotechnol Genet Eng Rev; 2000; 17():37-70. PubMed ID: 11255674
    [No Abstract]   [Full Text] [Related]  

  • 22. Preparation of Australia antigen free human albumin with polyethylene glycol.
    Polson A; Parker JR
    Prep Biochem; 1973; 3(1):31-45. PubMed ID: 4725231
    [No Abstract]   [Full Text] [Related]  

  • 23. Blood fractionation: proteins.
    Stryker MH; Bertolini MJ; Hao YL
    Adv Biotechnol Processes; 1985; 4():275-336. PubMed ID: 3902053
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of proteomes in various human plasma preparations by two-dimensional gel electrophoresis.
    Kim HJ; Kim MR; So EJ; Kim CW
    J Biochem Biophys Methods; 2007 Jun; 70(4):619-25. PubMed ID: 17368557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Continuous fractionation of human plasma.
    Mitra G; Lundblad J
    Biotechnol Bioeng; 1978 Jul; 20(7):1037-44. PubMed ID: 28798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Approaches to plasma fractionation for improved recovery and the development of potentially useful clinical factors.
    Johnson AJ; Mathews RW; Fulton AJ
    Clin Haematol; 1984 Feb; 13(1):3-15. PubMed ID: 6426834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Depletion of the high-abundance plasma proteins.
    Fountoulakis M; Juranville JF; Jiang L; Avila D; Röder D; Jakob P; Berndt P; Evers S; Langen H
    Amino Acids; 2004 Dec; 27(3-4):249-59. PubMed ID: 15592754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new protein fractionation method using ion-exchange chromatography and PEG precipitation.
    Björling H
    Vox Sang; 1985; 49(3):240-3. PubMed ID: 4049808
    [No Abstract]   [Full Text] [Related]  

  • 29. The development of plasma derivatives for clinical use. A symposium summary.
    Deutsch HF
    Vox Sang; 1972; 23(1):147-50. PubMed ID: 5081010
    [No Abstract]   [Full Text] [Related]  

  • 30. The development of plasma derivatives in Switzerland.
    Kistler P
    Vox Sang; 1972; 23(1):26-31. PubMed ID: 5081011
    [No Abstract]   [Full Text] [Related]  

  • 31. [Experiences in the preparation and analytical control of Cohn's plasma fraction I].
    Hofmann F; Thomas K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 93(3):316-9. PubMed ID: 4195275
    [No Abstract]   [Full Text] [Related]  

  • 32. [Electrophoretic studies of human plasma cryoprecipitates with a high content of antihemophilic globulin A].
    Kleint V; Wegner H
    Z Gesamte Inn Med; 1970 Apr; 25(7):312-4. PubMed ID: 5521442
    [No Abstract]   [Full Text] [Related]  

  • 33. The development of plasma derivatives in Australia.
    Schiff P
    Vox Sang; 1972; 23(1):38-43. PubMed ID: 4628156
    [No Abstract]   [Full Text] [Related]  

  • 34. Changes in factor VIII complex activities during the production of a clinical intermediate purity factor VIII concentrate.
    Prowse CV; Griffin B; Pepper DS; Dickson AJ; McQuillan TA; Dickson IH; Foster PR
    Thromb Haemost; 1981 Oct; 46(3):597-601. PubMed ID: 6797090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Competitive adsorption of plasma proteins at solid-liquid interfaces.
    Lensen HG; Breemhaar W; Smolders CA; Feijen J
    J Chromatogr; 1986 Apr; 376():191-8. PubMed ID: 3711192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differentiation of fibrinogen degradation products (FDP) in plasma by precipitation with polyethylene glycol.
    Zubler RH; Lambert PH; Miescher PA
    Schweiz Med Wochenschr; 1974 Sep; 104(39):1367-8. PubMed ID: 4213874
    [No Abstract]   [Full Text] [Related]  

  • 37. Production of cryoprecipitate of intermediate purity in a closed system thaw-siphon process.
    Mason EC; Pepper DS; Griffin B
    Thromb Haemost; 1981 Aug; 46(2):543-6. PubMed ID: 6795742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A modified protein precipitation procedure for efficient removal of albumin from serum.
    Chen YY; Lin SY; Yeh YY; Hsiao HH; Wu CY; Chen ST; Wang AH
    Electrophoresis; 2005 Jun; 26(11):2117-27. PubMed ID: 15880626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polyvinylpyrrolidone (PVP): a new precipitating agent for human and bovine factor VIII and fibrinogen.
    Casillas G; Simonetti C
    Br J Haematol; 1982 Apr; 50(4):665-72. PubMed ID: 6802165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multi-channel preparation of fresh blood an economic therapy with blood components.
    Schneider W; Glassner K; Fröhlich C; McCarty LJ
    Blut; 1974 Feb; 28(2):100-8. PubMed ID: 4130177
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.